
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **PDSS2**: Involved in the biosynthesis of coenzyme Q10, important for mitochondrial function.<br>- **PRKAR2B**: Regulatory subunit of protein kinase A, involved in various signaling pathways.<br>- **PIK3R1**: Regulatory subunit of PI3K, involved in cell growth and survival signaling.<br>- **NAMPT**: Involved in NAD biosynthesis, important for cellular metabolism and stress responses.<br>- **S100A10**: Involved in cell proliferation and differentiation, often associated with cancer progression.<br>- **KRT7**: A type II keratin, involved in the structural integrity of epithelial cells.<br>- **KRT19**: A type I keratin, often used as a marker for epithelial cells and certain cancer types.<br><br>### Step 2: List the Key Cell Type Markers<br>- **MUC15**: Mucin protein, often expressed in epithelial tissues.<br>- **MUCL1**: Mucin-like protein, associated with breast tissue.<br>- **CD24**: Cell surface protein, often used as a marker for epithelial and cancer stem cells.<br>- **IFI27**: Interferon-induced protein, associated with epithelial cells and immune response.<br>- **PRLR**: Prolactin receptor, associated with mammary gland development and breast tissue.<br>- **ANKRD30A**: Known as a breast cancer antigen, associated with breast tissue.<br>- **TSPAN13**: Tetraspanin family member, involved in cell adhesion and migration, often expressed in epithelial cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer and epithelial cell markers, we can cross-reference these markers:<br>- **KRT7** and **KRT19** are well-known markers for epithelial cells, particularly in breast tissue.<br>- **CD24** is commonly used as a marker for epithelial cells and cancer stem cells in breast cancer.<br>- **PRLR** and **ANKRD30A** are specific to breast tissue, indicating a mammary epithelial origin.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of epithelial markers such as **KRT7**, **KRT19**, **CD24**, and breast-specific markers like **PRLR** and **ANKRD30A**, the most probable general cell type is **epithelial cells**, specifically those associated with breast tissue.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells**: Characterized by the expression of **KRT19**, **PRLR**, and **CD24**, which are typical of luminal cells in the mammary gland.<br>2. **Basal/Myoepithelial Cells**: While less likely due to the lack of specific basal markers like KRT5/14, the presence of general epithelial markers could suggest a mixed population.<br>3. **Cancer Stem-like Cells**: The presence of **CD24** and **S100A10** could indicate a subpopulation with stem-like properties, often seen in breast cancer.<br><br>The most likely subtype, given the strong expression of luminal markers, is **Luminal Epithelial Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is primarily composed of epithelial cells, with a strong indication towards luminal epithelial cells. This is supported by the expression of key markers such as **KRT19**, **PRLR**, and **CD24**, which are characteristic of luminal cells in the mammary gland. The presence of breast-specific markers like **ANKRD30A** further supports this annotation.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:<br><br>1. **Marker Consistency**: <br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - Markers such as **KRT7**, **KRT19**, **CD24**, **PRLR**, and **ANKRD30A** are well-known markers for epithelial cells, particularly in breast tissue, and are present in the marker list.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation acknowledges the potential presence of mixed cell types, such as basal/myoepithelial cells and cancer stem-like cells, but concludes that the strongest evidence supports luminal epithelial cells. <br>   - The presence of markers like **CD24** and **S100A10** suggests a possible subpopulation with stem-like properties, which is appropriately flagged for consideration.<br><br>3. **Cross-referencing with Databases**:<br>   - The annotation correctly cross-references known databases and literature, supporting the identification of luminal epithelial cells as the primary cell type.<br><br>Overall, the annotation is well-supported by the marker list and the context of the dataset, and the potential for mixed cell types is appropriately considered.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal Epithelial Cells</li><li>Basal/Myoepithelial Cells</li><li>Cancer Stem-like Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough and methodical approach to identifying the cell types present in the single-cell dataset derived from breast cancer tissue. The analysis is well-structured, following a logical sequence of steps that include listing key functional and cell type markers, cross-referencing with known databases, and determining the most probable cell types.<br><br>1. **Correctness of the Annotations**: The annotations are scientifically accurate. The identification of epithelial cells, particularly luminal epithelial cells, is well-supported by the presence of markers such as KRT7, KRT19, CD24, PRLR, and ANKRD30A. These markers are well-documented in the literature as being associated with breast tissue and epithelial cells.<br><br>2. **Balanced Consideration of Multiple Markers**: The analysis effectively balances the use of different markers, considering both functional and cell type-specific markers. The inclusion of markers like PDSS2, PRKAR2B, and PIK3R1 highlights the consideration of functional aspects, while markers like MUC15, MUCL1, and CD24 emphasize cell type specificity. This balanced approach ensures a comprehensive understanding of the cell populations.<br><br>3. **Ability to Capture the General Picture**: The annotation captures the general picture of the cell populations present in the dataset. It acknowledges the potential presence of mixed cell types, such as basal/myoepithelial cells and cancer stem-like cells, which is crucial in the context of breast cancer. The analysis also considers the rank of the markers, giving appropriate weight to those appearing earlier in the list.<br><br>4. **Consideration of Marker Rank**: The annotation appropriately considers the rank of the markers, with key markers like PDSS2 and PRKAR2B being discussed early in the analysis. This reflects an understanding of the importance of marker rank in determining cell type identity.<br><br>5. **Potential Oversights**: While the analysis is comprehensive, it could have further explored the implications of markers like S100A10 and CD24 in the context of cancer stem-like cells. Additionally, the potential for basal/myoepithelial cells could have been discussed in more detail, given the complexity of breast cancer tissue.<br><br>Overall, the annotation is well-executed, scientifically sound, and provides a comprehensive view of the cell types present in the dataset. It effectively balances the use of multiple markers and considers the rank of the markers, resulting in a robust and accurate annotation.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    